Fundz

Viome, A Microbiome Startup, Raises $86.5M, Inks Distribution Deal With Cvs

PRIVATEAug 18, 2023

Amount Raised

$86.5 Million

Round Type

Funding Round

BellevueOtherBiotechnologyHealth CareScience And EngineeringGenetics

Description

Research on the human microbiome — microorganism communities that live in a part of your body such as your mouth or gut — has led to a number of insights and spurred further investigations into what makes up a healthy person. Combined with the continuing interest in alternative medicine, that is leading to some venture dollars getting channeled into at one prominent startup in the space. Viome — which has built a business out of assessing customers’ microbiomes, applying AI to the data, and using that to provide them with supplements and other guidance based on the findings — has raised $86.5 million to expand its business.

Quick answer

Viome raised $86.5 Million in a Funding Round round, dated August 18, 2023. Viome is based in Bellevue, Washington, United States.

How much did Viome raise?
Viome raised $86.5 Million in a Funding Round round on August 18, 2023.
What does Viome do?
Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions.
Where is Viome based and how big is it?
Viome is based in Bellevue, Washington, United States. Fundz records about 201 employees.
Who are the decision-makers at Viome?
Fundz holds 2 contacts at Viome, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Genetics around the same time

Companies in the same sectors as Viome that raised within 45 days of this round, from Fundz verified event records.

  • RedHill Biopharma Ltd raised $4M (Seed) on September 28, 2023.
  • Deka Biosciences, Inc. raised $20M (Series B) on September 28, 2023.
  • Geneos Therapeutics raised an undisclosed amount (Series A) on September 27, 2023.
  • Trait Biosciences Inc. raised $3.7M (Series A) on September 12, 2023.
  • Lexeo Therapeutics raised an undisclosed amount (Corporate Round) on August 28, 2023.
  • Advanced NanoTherapies raised $4M (Seed) on August 22, 2023.

Who to call at Viome, and when

A new round usually means Viome is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Viome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viome

Location

Bellevue, Washington, United States

About

Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health. Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan. With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging - at its optimum. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJim D., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Viome's next move

See what Strategic adds

Viome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.